TORONTO, ONTARIO, Nov. 09, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire – BioLife Sciences Inc. (OTCPK:BLFE) announces it has initiated the process of up-listing to the Over the Counter Quotation Bureau ...

BioLife shareholders will receive $11.25 ⁠in cash and 0.1442 shares of Repligen for each share, valuing ⁠the cell therapy tools supplier at $31 per share — a premium of about 6.2% to BioLife's last ...

Plasma donation and testing company BioLife Plasma Services LP in has invested $4 million to expand its testing laboratory in Hoover, Ala., and buy equipment to recycle biohazardous plastics waste ...

BioLife Solutions Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioLife Solutions, Inc. - BLFS Former Attorney General of Louisiana Charles C.

For decades, people seeking regenerative therapies, hormone treatments, or advanced wellness solutions have had to navigate a fragmented system. One physician might offer hormone replacement, another ...

TUKWILA, Wash.--(BUSINESS WIRE)--BioLife Plasma Services, part of the global biopharmaceutical company Takeda Pharmaceutical Company Limited, today announced the opening of an all-electric plasma ...

Halper Sadeh LLC, an investor rights law firm, is investigating the sale of BioLife Solutions, Inc. (NASDAQ: BLFS) to Repligen Corporation for $11.25 per share in cash and 0.1442 shares of Repligen ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Repligen Corp said on Wednesday it would buy BioLife Solutions in a cash-and-stock deal valued at about US$1.5 billion, to expand the drugmaking equipment provider’s presence in the fast-growing cell ...